Xenon Pharmaceuticals (XENE) Long-Term Debt Issuances (2018)
Xenon Pharmaceuticals' (XENE) quarterly Long-Term Debt Issuances came in at $3.5 million in Q3 2018.
Xenon Pharmaceuticals (XENE) Long-Term Debt Issuances (2018) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 1 years of Long-Term Debt Issuances data on file, last reported at $3.5 million in Q3 2018.
- On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $3.5 million in Q3 2018; TTM through Dec 2020 was $3.5 million, a N/A change from a year earlier, with the FY2020 full-year figure at -$16.7 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q3 2018 stood at $3.5 million.
- Over the last five years, Long-Term Debt Issuances for XENE reached as high as $3.5 million in Q3 2018 and fell as low as $3.5 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 3.46 Mn |
| Sep 30, 2018 | 3.46 Mn |